BRUSSELS -
The CEO of Pfizer, Albert Bourla, has refused for the second time in a row to appear before the European Parliament for a hearing on the negotiations carried out with the EU Commission for the supply of vaccines.
The president of the Eurochamber's special commission on Covid, Kathleen Van Brempt (S&D), reports this via Twitter.
"The European Parliament has the right to obtain full transparency" on contracts and "the failure of the EU Commission and Pfizer" to give answers "shows a lack of interest in the role of the EP and casts an unnecessary shadow on the success of the European vaccine strategy ", highlights the MEP.
"Comparing to the hearing in October we have no more information to share so I respectfully decline the invitation"
.
This was written by the CEO of Pfizer,
Albert Bourla,
in a letter addressed to the president of the special commission on Covid of the European Parliament, Kathleen Van Brempt (S & D), formalizing his refusal to appear before MEPs.
"A few weeks ago, our president for international markets, Janine Small, already testified before your committee," Bourla underlined, referring to the October session.
On that occasion, however, unlike Gilead Sciences, Sanofi, AstraZeneca and Moderna, all represented by their respective CEOs, Pfizer was the only company to send an executive.
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/KMEYMJKESBAZBE4MRBAM4TGHIQ.jpg)
